BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B. World J Gastroenterol 2015; 21(18): 5524-5531 [PMID: 25987775 DOI: 10.3748/wjg.v21.i18.5524]
URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5524.htm
Number Citing Articles
1
Mindie H Nguyen, Hwai-I Yang, An Le, Linda Henry, Nghia Nguyen, Mei-Hsuan Lee, Jian Zhang, Christopher Wong, Clifford Wong, Huy Trinh. Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched StudyThe Journal of Infectious Diseases 2019; 219(1): 10 doi: 10.1093/infdis/jiy391
2
P. Lampertico, H. L. Y. Chan, H. L. A. Janssen, S. I. Strasser, R. Schindler, T. Berg. Review article: long‐term safety of nucleoside and nucleotide analogues in HBV‐monoinfected patientsAlimentary Pharmacology & Therapeutics 2016; 44(1): 16 doi: 10.1111/apt.13659
3
Calvin Q. Pan, Zhongping Duan, Erhei Dai, Shuqin Zhang, Guorong Han, Yuming Wang, Huaihong Zhang, Huaibin Zou, Baoshen Zhu, Wenjing Zhao, Hongxiu Jiang. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral LoadNew England Journal of Medicine 2016; 374(24): 2324 doi: 10.1056/NEJMoa1508660
4
Chantelli Iamblaudiot Razafindrazoto, Tovo Harimanana Rabenjanahary, Andry Lalaina Rinà Rakotozafindrabe, Sedera Radoniaina Rakotondrasoa, Nitah Harivony Randriamifidy, Anjaramalala Sitraka Rasolonjatovo, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy, Haruki Komatsu. Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis BBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/1654620
5
Ming Wang, Qian Bian, Yunxia Zhu, Qiumei Pang, Lingzhi Chang, Ran Li, Benjamin C. Tiongson, Hua Zhang, Calvin Q. Pan. Real‐world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral loadAlimentary Pharmacology & Therapeutics 2019; 49(2): 211 doi: 10.1111/apt.15064
6
Manoj Kumar, Zaigham Abbas, Milad Azami, Maria Belopolskaya, A. K. Dokmeci, Hasmik Ghazinyan, Jidong Jia, Ankur Jindal, Han Chu Lee, Wei Lei, Seng Gee Lim, Chun-Jen Liu, Qiang Li, Mamun Al Mahtab, David H. Muljono, Madunil Anuk Niriella, Masao Omata, Diana A. Payawal, Shiv K. Sarin, Olivier Ségéral, Tawesak Tanwandee, Nirupma Trehanpati, Kumar Visvanathan, Jin Mo Yang, Man‑Fung Yuen, Yingjie Zheng, Y. H. Zhou. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancyHepatology International 2022; 16(2): 211 doi: 10.1007/s12072-021-10285-5
7
M. J. Tong, C. Q. Pan, S.‐H. B. Han, D. S.‐K. Lu, S. Raman, K.‐Q. Hu, J. K. Lim, H. W. Hann, A. D. Min. An expert consensus for the management of chronic hepatitis B in Asian AmericansAlimentary Pharmacology & Therapeutics 2018; 47(8): 1181 doi: 10.1111/apt.14577
8
Jiaming Zhu, Saro Khemichian, Dat Nghiem, Shi-Rong Zhang, Joyce Limurti, Takeshi Saito, Tse-Ling Fong. Comparison of Demographic and Clinical Characteristics of Hispanic and Asian Chronic Hepatitis B Patients in Southern CaliforniaJournal of Clinical Gastroenterology 2016; 50(7): 602 doi: 10.1097/MCG.0000000000000486
9
Shahnaz Sali, Maryam Nasiri. Tenofovir Response Rate and Adverse Effects in Patients with Chronic Hepatitis B Attending to Hepatitis Clinic at Labbafinejad HospitalJundishapur Journal of Natural Pharmaceutical Products 2019; 14(3) doi: 10.5812/jjnpp.63023
10
Jae Young Choe, Jae Sung Ko, Byung-Ho Choe, Jung Eun Kim, Ben Kang, Kyung Jae Lee, Hye Ran Yang. Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis BJournal of Korean Medical Science 2018; 33(2) doi: 10.3346/jkms.2018.33.e11
11
Kazumoto Murata, Masashi Mizokami. Possible biological mechanisms of entecavir versus tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2023; 38(5): 683 doi: 10.1111/jgh.16178
12
Calvin Q. Pan, Ming‐Hui Li, Wei Yi, Lu Zhang, Yao Lu, Hong‐Xiao Hao, Gang Wan, Wei‐Hua Cao, Xing‐Yue Wang, Chong‐Ping Ran, Ge Shen, Shu‐Ling Wu, Min Chang, Yuan‐Jiao Gao, Yao Xie. Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimensLiver International 2021; 41(7): 1498 doi: 10.1111/liv.14801
13
Sheila F. Lumley, Marion Delphin, Jolynne F. Mokaya, Cedric C.S. Tan, Emily Martyn, Motswedi Anderson, Ka Chun Li, Elizabeth Waddilove, Gloria Sukali, Louise O. Downs, Khadija Said, Dorcas Okanda, Cori Campbell, Eli Harriss, Yusuke Shimakawa, Philippa C. Matthews. A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovirJournal of Clinical Virology 2024; 174: 105711 doi: 10.1016/j.jcv.2024.105711